Showing 501 - 520 results of 115,966 for search '(( 5 ((a decrease) OR (mean decrease)) ) OR ( a ((non decrease) OR (nn decrease)) ))', query time: 1.99s Refine Results
  1. 501

    Blocking CD88 decreased ANCA antigen translocation, ANCA-induced respiratory burst and degranulation in C5a-primed neutrophils. by Jian Hao (160736)

    Published 2013
    “…B: blocking CD88 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). …”
  2. 502
  3. 503
  4. 504
  5. 505

    The surface area of breast tumors in PyMT transgenic mice was decreased after three weeks of voluntary wheel running. by Jorming Goh (490491)

    Published 2013
    “…C. Runners have a significant decrease in tumor size in mammary gland 1 after 5 weeks of running (p = 0.03). …”
  6. 506
  7. 507
  8. 508
  9. 509
  10. 510
  11. 511
  12. 512
  13. 513

    Statins Decrease Neuroinflammation and Prevent Cognitive Impairment after Cerebral Malaria by Patricia A. Reis (109310)

    Published 2012
    “…<div><p>Cerebral malaria (CM) is the most severe manifestation of <em>Plasmodium falciparum</em> infection in children and non-immune adults. Previous work has documented a persistent cognitive impairment in children who survive an episode of CM that is mimicked in animal models of the disease. …”
  14. 514

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”
  15. 515

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”
  16. 516
  17. 517

    Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

    Published 2015
    “…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”
  18. 518
  19. 519
  20. 520